AR015465A1 - Una formulacion parenteral que comprende 5h-dibenz (b,f)azepin-5-carboxamida y agua o un solvente basado en agua, una forma de dosificacion unitaria y unrecipiente que los comprende y el uso de dicha formulacion para la preparacion de un medicamento - Google Patents
Una formulacion parenteral que comprende 5h-dibenz (b,f)azepin-5-carboxamida y agua o un solvente basado en agua, una forma de dosificacion unitaria y unrecipiente que los comprende y el uso de dicha formulacion para la preparacion de un medicamentoInfo
- Publication number
- AR015465A1 AR015465A1 ARP980105003A ARP980105003A AR015465A1 AR 015465 A1 AR015465 A1 AR 015465A1 AR P980105003 A ARP980105003 A AR P980105003A AR P980105003 A ARP980105003 A AR P980105003A AR 015465 A1 AR015465 A1 AR 015465A1
- Authority
- AR
- Argentina
- Prior art keywords
- water
- formulation
- dibenz
- azepin
- carboxamide
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 6
- ZFXVFMBOFIEPII-UHFFFAOYSA-N 1h-azepine-4-carboxamide Chemical compound NC(=O)C1=CC=CNC=C1 ZFXVFMBOFIEPII-UHFFFAOYSA-N 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 3
- 239000002552 dosage form Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 title abstract 2
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001037 epileptic effect Effects 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721497.7A GB9721497D0 (en) | 1997-10-09 | 1997-10-09 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015465A1 true AR015465A1 (es) | 2001-05-02 |
Family
ID=10820342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105003A AR015465A1 (es) | 1997-10-09 | 1998-10-07 | Una formulacion parenteral que comprende 5h-dibenz (b,f)azepin-5-carboxamida y agua o un solvente basado en agua, una forma de dosificacion unitaria y unrecipiente que los comprende y el uso de dicha formulacion para la preparacion de un medicamento |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US6316417B1 (enExample) |
| EP (1) | EP1033988B1 (enExample) |
| JP (2) | JP2001519395A (enExample) |
| KR (1) | KR100760326B1 (enExample) |
| CN (1) | CN1210032C (enExample) |
| AR (1) | AR015465A1 (enExample) |
| AT (1) | ATE257383T1 (enExample) |
| AU (1) | AU748034B2 (enExample) |
| BR (1) | BR9812861A (enExample) |
| CA (1) | CA2304661C (enExample) |
| CO (2) | CO4950520A1 (enExample) |
| CZ (1) | CZ298900B6 (enExample) |
| DE (1) | DE69821024T2 (enExample) |
| DK (1) | DK1033988T3 (enExample) |
| ES (1) | ES2214738T3 (enExample) |
| GB (1) | GB9721497D0 (enExample) |
| HU (1) | HU226106B1 (enExample) |
| ID (1) | ID24134A (enExample) |
| IL (1) | IL135123A0 (enExample) |
| MY (1) | MY122129A (enExample) |
| NO (1) | NO327263B1 (enExample) |
| NZ (1) | NZ503526A (enExample) |
| PE (1) | PE121998A1 (enExample) |
| PL (1) | PL192287B1 (enExample) |
| PT (1) | PT1033988E (enExample) |
| RU (1) | RU2242231C2 (enExample) |
| SK (1) | SK286253B6 (enExample) |
| TR (1) | TR200000870T2 (enExample) |
| TW (1) | TW584563B (enExample) |
| WO (1) | WO1999018966A1 (enExample) |
| ZA (1) | ZA989183B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| WO2007041524A2 (en) * | 2005-09-30 | 2007-04-12 | Ovation Pharmaceuticals, Inc. | Novel parenteral carbamazepine formulation |
| US20100204178A1 (en) | 2006-10-02 | 2010-08-12 | James Cloyd | Novel parenteral carbamazepine formulation |
| KR101478164B1 (ko) * | 2006-02-09 | 2014-12-31 | 산텐 세이야꾸 가부시키가이샤 | 안정한 제제와 그 제조 및 사용 방법 |
| US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| CN101711739B (zh) * | 2008-10-08 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 卡马西平的口服药物组合物 |
| CN105726466A (zh) * | 2014-12-10 | 2016-07-06 | 辽宁药联制药有限公司 | 一种奥卡西平注射剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202311A (en) * | 1988-08-19 | 1993-04-13 | Children's Medical Center Corporation | Stabilized fgf composition |
| EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
| ES2081965T3 (es) * | 1989-12-27 | 1996-03-16 | Ciba Geigy Ag | Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser. |
| US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
| RU2020972C1 (ru) * | 1991-02-07 | 1994-10-15 | Мегдятов Рашид Салехович | Способ лечения невралгии тройничного нерва |
| US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
| FR2702148B1 (fr) | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US5466683A (en) * | 1994-08-25 | 1995-11-14 | Teva Pharmaceutical Industries Ltd. | Water-soluble analogs of carbamazepine |
-
1997
- 1997-10-09 GB GBGB9721497.7A patent/GB9721497D0/en not_active Ceased
-
1998
- 1998-09-17 TW TW087115501A patent/TW584563B/zh not_active IP Right Cessation
- 1998-10-05 CO CO98057677A patent/CO4950520A1/es unknown
- 1998-10-05 CO CO98057677D patent/CO5090854A1/es unknown
- 1998-10-07 TR TR2000/00870T patent/TR200000870T2/xx unknown
- 1998-10-07 BR BR9812861-2A patent/BR9812861A/pt not_active Application Discontinuation
- 1998-10-07 HU HU0004362A patent/HU226106B1/hu not_active IP Right Cessation
- 1998-10-07 EP EP98950110A patent/EP1033988B1/en not_active Expired - Lifetime
- 1998-10-07 CN CNB988099888A patent/CN1210032C/zh not_active Expired - Fee Related
- 1998-10-07 WO PCT/EP1998/006382 patent/WO1999018966A1/en not_active Ceased
- 1998-10-07 RU RU2000110741/15A patent/RU2242231C2/ru not_active IP Right Cessation
- 1998-10-07 AT AT98950110T patent/ATE257383T1/de not_active IP Right Cessation
- 1998-10-07 SK SK505-2000A patent/SK286253B6/sk not_active IP Right Cessation
- 1998-10-07 PE PE1998000950A patent/PE121998A1/es not_active Application Discontinuation
- 1998-10-07 PL PL339446A patent/PL192287B1/pl not_active IP Right Cessation
- 1998-10-07 CA CA002304661A patent/CA2304661C/en not_active Expired - Fee Related
- 1998-10-07 AR ARP980105003A patent/AR015465A1/es unknown
- 1998-10-07 DK DK98950110T patent/DK1033988T3/da active
- 1998-10-07 NZ NZ503526A patent/NZ503526A/xx unknown
- 1998-10-07 CZ CZ20001279A patent/CZ298900B6/cs not_active IP Right Cessation
- 1998-10-07 DE DE69821024T patent/DE69821024T2/de not_active Expired - Lifetime
- 1998-10-07 ID IDW20000588A patent/ID24134A/id unknown
- 1998-10-07 ES ES98950110T patent/ES2214738T3/es not_active Expired - Lifetime
- 1998-10-07 KR KR1020007003210A patent/KR100760326B1/ko not_active Expired - Fee Related
- 1998-10-07 US US09/509,973 patent/US6316417B1/en not_active Expired - Fee Related
- 1998-10-07 AU AU96298/98A patent/AU748034B2/en not_active Ceased
- 1998-10-07 IL IL13512398A patent/IL135123A0/xx unknown
- 1998-10-07 MY MYPI98004586A patent/MY122129A/en unknown
- 1998-10-07 PT PT98950110T patent/PT1033988E/pt unknown
- 1998-10-07 JP JP2000515601A patent/JP2001519395A/ja not_active Withdrawn
- 1998-10-08 ZA ZA989183A patent/ZA989183B/xx unknown
-
2000
- 2000-04-04 NO NO20001730A patent/NO327263B1/no not_active IP Right Cessation
-
2001
- 2001-11-09 US US10/037,090 patent/US6458770B1/en not_active Expired - Fee Related
-
2005
- 2005-05-06 JP JP2005135218A patent/JP2005281314A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1279383B1 (it) | Composizione farmaceutica stabilizzata contenente un agente antineoplastico degradabile, relativo solvente stabilizzante avente | |
| NO953769L (no) | Pakninger for brettede servietter til engangsbruk og som bevirker utbretting | |
| ES2192338T3 (es) | Papel tisu que tiene una mezcla suavizante anhidra sustantiva depositado sobre el. | |
| ITRM910827A1 (it) | Cartuccia ermetica contenente una dose di sostanze per la preparazione di un prodotto liquido, componente per la raccolta di prodotto liquido e componente di perforazione e iniezione di liquido per detta cartuccia. | |
| MX9402922A (es) | Composiciones farmaceuticamente aceptables mejoradas. | |
| MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
| ES2149264T3 (es) | Agente terapeutico para el tratamiento de melanomas. | |
| BRPI0113564A8 (pt) | composição para produto pessoal, composição bifásica e sistema de limpeza | |
| AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
| BR9800323A (pt) | Formulação contendo gonadotropina líquida processo para preparar a mesma cartucho dispositivo de administração e uso de gonadotropina | |
| MXPA97007996A (es) | Preparado para el transporte de sustancias activas a traves de barreras. | |
| AR018026A1 (es) | Un material tramado al azar con suavidad mejorada y propiedades de barrera y peso base reducido | |
| CA2102072A1 (en) | Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence | |
| BR9809571A (pt) | Composição medicinal e processo para produzì-la | |
| KR910019620A (ko) | 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료 | |
| AR024959A1 (es) | Una composicion farmaceutica liquida basada en paracetamol | |
| BR9705143A (pt) | Derivados de 10,13,15-trioxatriciclo [9.2.1.1(9.6)] -pentadecanona, processo para a sua preparação e medicamentos que contém estes compostos | |
| AR242907A1 (es) | Dispositivo de doble punta para dosificar y suministrar medicamentos. | |
| ID19931A (id) | Senyawa cincin 7-anggota terfusi tersubstitusi sulfonamida, penggunaannya sebagai obat-obatan, dan pembuatan sediaan farmasi yang mengandung senyawa tersebut | |
| ES2176702T3 (es) | Antimicoticos con alta liberacion de sustancia activa. | |
| AR016350A1 (es) | Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos | |
| ID21282A (id) | Senyawa-senyawa cincin beranggota-5 terpadu yang disubstitusi sulfonamida, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung senyawa tersebut | |
| PE121998A1 (es) | Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida | |
| KR970704442A (ko) | 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia) | |
| DE69616591D1 (de) | Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |